Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALKBH5 is required to maintain proper SETDB1 protein levels associated with meiotic sex chromosome inactivation. | Commun Biol | 2026 | 42443451 | PubTator, text mining | PubMed |
| An H3K18la-ALKBH5-Runx2-LDHA positive feedback loop promotes vascular calcification in the osteogenic phenotypic transition of vascular smooth muscle cells. | Cell Signal | 2026 | 42431494 | PubTator, text mining | PubMed |
| EIF4A3/ALKBH5 axis promotes meningioma cell growth, invasion, and resistance to CD8+ T cell-mediated cytotoxicity by inducing M2 polarization. | Clin Immunol | 2026 | 42409229 | PubTator, text mining | PubMed |
| α-ketoglutarate accumulation orchestrates immunosuppressive metabolic remodeling to drive cetuximab resistance in metastatic colorectal cancer. | Cell Death Dis | 2026 | 42380087 | PubTator, text mining | PubMed |
| The role of macrophage-myofibroblast transition in the pathogenesis of multi-organ fibrosis. | Tissue Cell | 2026 | 42372502 | PubTator, text mining | PubMed |
| (+)-Miliusol suppresses the Warburg effect and induces regulated cell death in triple-negative breast cancer through targeting EIF3D and remodeling cancer metabolism. | Acta Pharm Sin B | 2026 | 42368564 | PubTator, text mining | PubMed |
| Spatial Confinement-Accelerated DNAzyme Nanoassembly for Demethylase Imaging and Chemoresistance Evaluation in Living Cells. | ACS Nano | 2026 | 42361124 | PubTator, text mining | PubMed |
| oHSV-1-modulated m6A methylation reprogramming through ALKBH5-mediated suppression of CARM1 induced apoptosis in glioblastoma. | Virol J | 2026 | 42343346 | PubTator, text mining | PubMed |
| RBM12 Maintains Glioma Stem Cells by Activating Amino Acid-Dependent mTORC1 Signaling via SLC7A5 mRNA Stabilization. | Adv Sci (Weinh) | 2026 | 42325209 | PubTator, text mining | PubMed |
| Hypoxia-induced m6A demethylation promotes hepatocellular carcinoma progression by preventing the degradation of Gal-1 mRNA. | Genes Dis | 2026 | 42290655 | PubTator, text mining | PubMed |
| Regulation of trophoblast fusion dysfunction in preeclampsia by the NCK1/EIF3D/PPARG axis. | Biol Res | 2026 | 42271516 | PubTator, text mining | PubMed |
| Erratum: Hypoxia-induced m6A demethylase ALKBH5 promotes ovarian cancer tumorigenicity by decreasing methylation of the lncRNA RMRP. | Am J Cancer Res | 2026 | 42266741 | PubTator, text mining | PubMed |
| ALKBH5 promotes the progression of cisplatin-resistant oral squamous cell carcinoma by regulating FOXA1 expression via m6A RNA methylation : Funding. | Daru | 2026 | 42251238 | PubTator, text mining | PubMed |
| Roles of m6A erasers FTO and ALKBH5 in drug resistance of hepatocellular carcinoma: mechanisms and clinical implications. | Gene | 2026 | 42248266 | PubTator, text mining | PubMed |
| MUC2 promotes cholesterol efflux in foam cells through ALKBH5-mediated m6A modification of ABCA1 mRNA. | Clin Investig Arterioscler | 2026 | 42243019 | PubTator, text mining | PubMed |
| ALKBH5 aggravates scarring after glaucoma surgery via m6A-YTHDF2-mediated NLRP3 mRNA stabilization. | Cell Death Differ | 2026 | 42218253 | PubTator, text mining | PubMed |
| Regulatory mechanisms and therapeutic potential of N6-methyladenosine modification in retinal diseases (Review). | Mol Med Rep | 2026 | 42212360 | PubTator, text mining | PubMed |
| Immunometabolic reprogramming in rheumatoid arthritis: the epitranscriptomic role of N6-methyladenosine in innate and adaptive immunity. | Front Immunol | 2026 | 42212124 | PubTator, text mining | PubMed |
| Glycolytic reprogramming in endometriosis: molecular mechanisms, immune modulation, and non-hormonal therapeutic opportunities. | BMC Womens Health | 2026 | 42186039 | PubTator, text mining | PubMed |
| Icariin suppresses glycolysis in prostate cancer by upregulating ALKBH5 to mediate EARS2 m6A demethylation. | J Mol Histol | 2026 | 42185511 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=3